Trials / Completed
CompletedNCT05871905
[14 C] Study on Mass Balance of TY-9591 in Healthy Chinese Subjects
[14 C] Study on Mass Balance of TY-9591 in Healthy Chinese Adult Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- TYK Medicines, Inc · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
\[14 C\] Mass balance clinical trial of TY-9591 in healthy Chinese subjects
Detailed description
This is a single-center, non-randomized, one-arm, open trial in healthy adult subjects. The study population is male healthy subjects. The trial consisted of a screening period, a trial period and a follow-up period. A total of 6-10 healthy Chinese adult male subjects were planned to be enrolled and divided into groups according to specific conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TY-9591 | C14 TY-9591 |
Timeline
- Start date
- 2023-06-19
- Primary completion
- 2023-11-06
- Completion
- 2024-06-20
- First posted
- 2023-05-23
- Last updated
- 2024-12-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05871905. Inclusion in this directory is not an endorsement.